Drug Profile
Estradiol/levonorgestrel transdermal - Elan Pharma
Alternative Names: Nuvelle TSLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Elan Pharma International
- Developer Bayer Schering Pharma
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnanes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome
Most Recent Events
- 07 Feb 2019 Chemical structure information added
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
- 29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG